New inhalational anaesthetics;Neue Inhalationsanasthetika

Anaesthesist

Volumn 45, Issue 8, 1996, Pages 674-693

  Conzen, P ^a   Nuscheler, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

anaesthetics, volatile: sevoflurane, desflurane; pharmacodynamics; pharmacokinetics

Indexed keywords

DESFLURANE; ENFLURANE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PROPOFOL; SEVOFLURANE; DRUG DERIVATIVE; ETHER DERIVATIVE;

ADRENERGIC STIMULATION; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; DRUG METABOLISM; DRUG SOLUBILITY; HEART DISEASE; HUMAN; INHALATION ANESTHESIA; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEPHROTOXICITY; REVIEW; CHEMISTRY;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ETHERS; HUMANS; ISOFLURANE; METHYL ETHERS;

EID: 0029838485     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050301     Document Type: Review

References (82)

1. Baum J, Sachs G, Driesch C vd, Stanke HG (1995) Carbon monoxide generation in carbon dioxide absorbents. Anesth Analg 81: 144-146
2. Bernard JM, Wouters PF, Doursout MF, Florence B, Chelly JE, Merin RG (1990) Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology 72: 659-662
3. Binstock WB, Berkowitz R, Eyrich K, Hannallah RS, Apfelbaum JL (1994) A comparison of sevoflurane and halothane for induction and maintenance of anesthesia in pediatric ASA I and II outpatients. Anesthesiology 81:A1313
4. Bito H, Ikeda K (1994) Closed-circuit anesthesia with sevoflurane in humans. Anesthesiology 80: 71-76
5. Bito H, Ikeda K (1994) Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Anesthesiology 81: 340-345
6. Bito H, Ikeda K (1996) Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia. Anesth Analg 82: 173-176 Bito et al. tragen mit zahlreichen Studien auch bei prolongierten Anästhesien zur Bewertung der klinischen Relevanz von Compound A während Niedrigfluß-narkosen bei.
7. Boban M, Stowe DF, Buljubasic N, Kampine JP, Bosnjak ZJ (1992) Direct comparative effects of isoflurane and desflurane in isolated guinea pig hearts. Anesthesiology 76: 775-780
8. Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K (1992) Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 74: 79-88 Mit umfangreicher Methodik werden an diesem Tiermodell die Einflüsse von Sevofluran und Isofluran auf wichtige Parameter der Hämodynamik und auf die organspezifischen Perfusionsverhältnisse untersucht.
9. Conzen PF, Nuscheler M, Melotte A, Verhaegen M, Leupolt T, van Aken H, Peter K (1995) Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurance or enflurane. Anesth Analg 81: 569-575
10. Conzen PF (1991) Noch unveröffentlichte Daten
11. Cousins MJ, Mazze RI (1973) Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA 225: 1611-1616
12. Daniel M, Eger EI, Weiskopf RB, Noorani M (1996) Propofol fails to attenuate the cardiovascular response to rapid increases in desflurane concentration. Anesthesiology 84: 75-80
13. Doi M, Ikeda K (1987) Respiratory effects of sevoflurane. Anesth Analg 66: 241-244
14. Doi M, Ikeda K (1993) Airway irritation produced by volatile anaesthetics during brief inhalation: comparison of halothane, enflurane, isoflurane and sevoflurane. Can J Anaesth 40: 122-126 Methodologisch einfaches, aber sehr pragmatisches Studiendesign zur Einschätzung der Atemwegsirritation verschiedener Inhalationsanästhetika.
15. Dubin SA, Huang S, Martin E, List W, Schachter SA (1994) Multicenter comparative study evaluating sevoflurane versus propofol in anesthesia maintenance and recovery in adult outpatients. Anesthesiology 81:A2
16. Ducart A, Adnet P, Renaud B, Riou B, Krivosic-Horber R (1995) Malignant hyperthermia during sevoflurane administration. Anesth Analg 80: 609-611
17. Ebert TJ, Muzi M, Lopatka CW (1994) Effects of sevoflurane on hemodynamics and sympathetic neural activity in humans: a comparison to isoflurane. Anesthesiology 81:A133
18. Ebert TJ, Muzi M, Lopatka CW (1995) Neurocirculatory responses to sevoflurane in humans. Anesthesiology 83: 88-95 Eine von zahlreichen Veröffentlichungen dieser Arbeitsgruppe zum Problem der Sympathikusaktivierung durch volatile Anästhetika. Sehr aussagekräftiger Vergleich von Sevofluran und Desfluran.
19. Eger EI (1994) New inhaled anesthetics. Anesthesiology 80: 906-922
20. Fang ZX, Eger EI (1995) Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and baralyme in a standard anesthetic circuit. Anesth Analg 81: 564-568
21. Fang ZX, Eger EI, Laster MJ, Chortkoff BS, Kandel L, Ionescu P (1995) Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and baralyme. Anesth Analg 80: 1187-1193
22. 2 absorbants during low-flow anesthesia in surgical patients. Anesthesiology 77: 1064-1069
23. Frink EJ, Nogami W, Morgan SE, Salmon R (1995) Desflurane Anesthesia using dry baralyme produces high carboxyhemoglobin levels in pigs. Anesthesiology 83:A294
24. Frink EJ, Malan TP, Patel CB, Shupak R, Brown EA, Morgan SE (1995) Hepatocellular function following sevofluran or isoflurane anesthesia in cirrhotic patients. Anesthesiology 83:A329
25. Frink EJ, Green WB, Brown EA, Malcomson M, Hammond LC, Valencia FG, Brown BR (1996) Compound A concentrations during sevoflurane anesthesia in children. Anesthesiology 84: 566-571 Die Arbeitsgruppe um Frink hat mit zahlreichen Untersuchungen zur Evaluierung der potentiellen Nephrotoxizität von Sevofluran beigetragen. Hier die erste publizierte Studie mit Bestimmung von Compound A während Kinderanästhesie.
26. Funk W, Moldaschl J, Fujita Y, Taeger P, Hobbhahn J (1996) Sevofluran oder Halothan bei inhalativ eingeleiteten Narkosen im Kindesalter. Anästhesiequalität und Serum-Fluoridspiegel. Anaesthesist 45: 22-30
27. Ghouri AF, Bodner M, White PF (1991) Recovery profile after desflurane/nitrous oxide versus isoflurane/nitrous oxide in outpatients. Anesthesiology 74: 419-424
28. Gonsowski BS, Laster MJ, Eger EI, Ferrell LD, Kerschmann RL (1994) Toxicity of compound A in rats. Anesthesiology 80: 556-565
29. Harke H, Schmidt K, Gretenkort K, Hommerich P, Deutschmann S, Eckes C, Hense W, Kleemann A, Rehorn W, Stöcker H, Leffers B, Blazejak J, Felix S, Fischer A, Fuhrmeister O, Gerecht A, Hackstein N, Knops H-J, Kostecka D, Ladleif H-U, Nicolas S, Olligs R, Rethage B, Schrama B, Seifert H, Staita K, Thater A, Urbanek C, Widdra S, Wielen R vd (1995) Qualitätsvergleich von modifizierter Neurolept-, balancierter und intravenöser Anästhesie, Teil 2. Ergebnisse der Krefelder Studie 1992. Anaesthesist 44: 687-694 Prospektive single-center-Studie an über 1100 Patienten zum Vergleich der Qualität verschiedener Anästhesieverfahren.
30. Hartman CJ, Pagel PS, Kampine JP, Schmeling WT, Warltier DC (1991) Influence of desflurane on regional distribution of coronary blood flow in a chronically instrumented canine model of multivessel coronary artery obstruction. Anesth Analg 72: 289-299
31. Helman JD, Leung JM, Bellows WH, Pineda N, Roach GW, Reeves JD, Howse J, McEnany T, Mangano DT (1992) The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. Anesthesiology 77: 47-62
32. Van Hemelrijck J, Smith I, White PF (1991) Use of desflurane for outpatient anesthesia. Anesthesiology 75: 197-203
33. Higuchi H, Sumikura H, Sumita S, Arimura S, Takamatsu F, Kanno M, Satoh T (1995) Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 83: 449-458
34. Isner RJ, Malan TP, Frink EJ, Brown ER, Morgan SE, Brown BR (1993) Quantification of inhaled compound A concentrations during prolonged sevoflurane anesthesia in volunteers. Anesthesiology 79:A349
35. Jellish WS, Lien C, Fontenot HJ, Hall R (1994) Sevoflurane versus propofol for anesthesia induction and maintenance in adult in patients. Anesthesiology 81: A367
36. Jin L, Baillie A, Davis MR, Kharach ED (1995) Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats: evidence for glutathione and cysteine conjugated formation and the role of renal cysteine conjugate β-lyase. Biochem Biophys Res Commun 210: 498-506 Die Ergebnisse dieser Arbeit zeigen, daß das Tiermodell der Ratte für Compound A assoziierte Nephrotoxizität nur eingeschränkt auf den Menschen übertragbar ist. Unterschiedliche Enzymaktivitäten zwischen Ratte und Mensch bedingen für die Toxizität durch Compound A bei der Ratte ein vielfach höheres Potential als beim Menschen.
37. Johnson JO, Sperry RJ, Lam A, Artru A (1995) A phase III, randomized, open-label study to compare sevoflurane and isoflurane in neurosurgical patients. Anesth Analg 80:S214
38. Katoh T, Ikeda K (1992) Minimum alveolar concentration of sevoflurane in children. Br J Anaesth 68: 139-141
39. Keller KA, Callan C, Prokocimer P, Delgado-Herrera L, Friedman MB, Hoffman GM, Wooding WL, Cusick PK, Krasula RW (1995) Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (Pife), in sprague-dawley rats. Anesthesiology 83: 1220-1232 Übersichtliche Darstellung und Diskussion der Toxizität von Compound A bei der Ratte.
40. Kersten JR, Braver AP, Pagel PS, Tessmer JP, Warltier DC (1994) Perfusion of ischemic myocardium during anesthesia with sevoflurane. Anesthesiology 81: 995-1004
41. Kharasch ED, Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79: 795-807
42. Kharasch ED, Hankins DC, Thummel KE (1995) Human kidney methoxyflurane and sevoflurane metabolism. Anesthesiology 82: 689-699 Vorläufiger Höhepunkt einer Reihe von Arbeiten, die den Metabolismus volatiler Anästhetika behandeln. In dieser Untersuchung bestimmen Kharasch et al. den Umfang der Metabolisierung von Sevofluran und Methoxyfluran in den Mikrosomen menschlicher Nieren und leiten daraus neue Hypothesen zur Pathophysiologie der Fluoridtoxizität von Methoxyfluran ab.
43. Kharasch ED (1995) Inhalational anesthetic toxicity: current controversies. ASA Annual Refresher Course Lectures, p 264
44. Kikura M, Ikeda K (1993) Comparison of effects of sevoflurane/nitrous oxide and enflurane/nitrous oxide on myocardial contractility in humans. Anesthesiology 79: 235-243 Die Autoren vergleichen bei Patienten per echokardiographischer Technik die Auswirkungen von Sevofluran und Enfluran auf die myokardiale Funktion.
45. Kind PRN (1982) N-Acetyl-β-D-glucosaminidase in urine of patients with renal disease, and alter renal transplants and surgery. Clin Chim Acta 119: 89-97
46. Kitaguchi K, Ohsumi H, Kuro M, Nakajima T, Hayashi Y (1993) Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiology 79: 704-709
47. Lentz RE (1995) CO poisoning during anesthesia poses puzzles. J Clin Monit 11: 66-67
48. Lerman J, Sikich N, Kleinman S, Yentis S (1994) The pharmacology of sevoflurane in infants and children. Anesthesiology 80: 814-824
49. Loscar M, Allhoff T, Ott E, Conzen P, Peter K (1996) Aufwachverhallen und kognitive Funktion nach Desfluran oder Isofluran. Anaesthesist 45: 140-145
50. Lutz LJ, Milde JH, Newberg Milde L (1990) The cerebral functional, metabolic, and hemodynamic effects of desflurane in dogs. Anesthesiology 73: 125-131
51. McGrath B, Hodgins L (1995) The effect of sevoflurane vs isoflurane on renal function in patients with renal insufficiency. Anesth Analg 80:S312
52. Merin RG, Bernard JM, Doursout MF, Cohen M, Chelly JE (1991) Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiology 74: 568-574 Am Tiermodell des Hundes werden die grundlegenden Einflüsse von Desfluran und Isofluran auf kardiovaskuläre Parameter und organspezifische Perfusion aufgezeichnet und verglichen.
53. Moon RE, Meyer AF, Scott DL, Fox E, Millington DS, Norwood DL (1990) Intraoperative carbon monoxide toxicity. Anesthesiology 73:A1049
54. Moon RE, Ingram C, Brunner EA, Meyer AF (1991) Spontaneous generation of carbon manoxide within anesthetic circuits. Anesthesiology 75:A873
55. Moore MA, Weiskopf RB, Eger EI, Wilson C, Lu G (1993) Arrhythmogenic doses of epinephrin are similar desflurane or isoflurane anesthesia in humans. Anesthesiology 79: 943-947
56. Motsch J, Wandel C, Neff S, Martin E (1996) Eine vergleichende Untersuchung zum Einsatz von Sevofluran und Propofol bei tageschirurgischen Eingriffen. Anaesthesist 45: S57-S62
57. Nakamura K, Toda H, Hatano Y, Mori K (1993) Comparisons of the direct effects of sevoflurane, isoflurane and halothane on isolated canine coronary arteries. Can J Anaesth 40: 257-261
58. Navarro R, Weiskopf RB, Moore MA, Lockhart S, Eger EI, Koblin D, Lu G, Wilson C (1994) Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine. Anesthesiology 80: 545-549
59. Nuscheler M, Conzen P, Schwender D, Peter K (1996) Fluoridinduzierte Nephrotoxizität: Fakt oder Fiktion? Anaesthesist 45:S32-S40
60. Ornstein E, Young WL, Fleischer LH, Ostapkovich N (1993) Desflurane and isoflurane have similar effects on cerebral blood flow in patients with intracranial mass lesions. Anesthesiology 79: 498-502
61. Pacentine GG, Muzi M, Ebert TJ (1995) Effects of fentanyl on sympathetic activation associated with the administration of desflurane. Anesthesiology 82: 823-831
62. Philip BK, Kallar SK, Bogetz MS, Scheller MS, Wetchler BV (1993) Multicenter comparison of sevoflurane with isoflurane in nitrous oxide for ambulatory surgery. Anesthesiology 79: A40
63. Rampil IJ, Lockhart SH, Zwass MS (1991) Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 74: 429-433
64. Rampil IJ, Lockhart SH, Eger EI, Yasuda N, Weiskopf RB, Cahalan MK (1991) The electroencephalographic effects of desflurane in humans. Anesthesiology 74: 434-439
65. Sarner JB, Levine M, Davis PJ, Lerman J, Cook DR, Motoyama EK (1995) Clinical characteristics of sevoflurane in children. A comparison with halothane. Anesthesiology 82: 38-46
66. Scheller MS, Saidman LJ, Partridge BL (1988) MAC of sevoflurane in humans and the New Zealand white rabbit. Can J Anaesth 35: 153-156
67. Scheller MS, Nakakimura K, Fleischer JE, Zornow MH (1990) Cerebral effects of sevoflurane in the dog: comparison with isoflurane and enflurane. Br J Anaesth 65: 388-392
68. Stickler R, Callan C, Sayre J, Blahunka K, Prokocimer P (1994) Incidence of inorganic fluoride concentrations ≥50 μmol/L in sevoflurane comparative clinical studies. Anesthesiology 81:A1283
69. Strum DP, Eger EI (1987) Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 66: 654-656
70. Taivainen T, Tiainen P, Meretoja OA, Räihä L, Rosenberg PH (1994) Comparison of the effects of sevoflurane and halothane on the quality of anaesthesia and serum glutathione transferase alpha and fluoride in paediatric patients. Br J Anaesth 73: 590-595
71. Taylor RH, Lerman J (1991) Minimum alveolar concentration of desflurane and hemodynamic responses in neonates, infants, and children. Anesthesiology 75: 975-979
72. Thomson IR, Bowerting JB, Hudson RJ, Frais MA, Rosenbloom M (1991) A comparison of desflurane and isoflurane in patients undergoing coronary artery surgery. Anesthesiology 75: 776-781
73. Vanlinthout LEH, Booij LHDJ, Van Egmond J, Robertson EN (1996) Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium. Br J Anaesth 76: 389-395
74. Wallin RF, Regan BM, Napoli MD, Stern IJ (1975) Sevoflurane: a new inhalational anesthetic agent. Anesth Analg 54: 758-766
75. Weiskopf RB, Eger EI, Noorani M, Daniel M (1994) Repetitive rapid increases in desflurane concentration blunt transient cardiovascular stimulation in humans. Anesthesiology 81: 843-849
76. Weiskopf RB, Eger EI, Noorani M, Daniel M (1994) Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans. Anesthesiology 81: 1350-1355
77. Wright PMC, Hart PS, Lau M, Brown R, Fisher DM (1994) Potentiation of vecuronium by desflurane vs isoflurane. Anesthesiology 81:A1114
78. Yasuda N, Lockhart SH, Eger EI, Weiskopf RB, Liu J, Laster M, Taheri S, Peterson NA (1991) Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 72: 316-324 Viel zitierte Studie aus der Arbeitsgruppe um Ted Eger, die den Einfluß der Löslichkeit auf die unterschiedliche Kinetik moderner Inhalationsanästhetika exemplarisch mit Messungen an Probanden untersucht.
79. Yurino M, Kimura H (1993) Induction of anesthesia with sevoflurane, nitrous oxide, and oxygen: a comparison of spontaneous ventilation and vital capacity rapid inhalation induction (VCRII) techniques. Anesth Analg 76: 598-601
80. Yurino M, Kimura H (1995) A comparison of vital capacity breath and tidal breathing techniques for induction of anaesthesia with high sevoflurane concentrations in nitrous oxide and oxygen. Anaesthesia 50: 308-311
81. Zaleski L, Abello D, Gold MI (1993) Desflurane versus isoflurane in patients with chronic hepatic and renal disease. Anesth Analg 76: 353-356
82. Zwass MS, Fisher DM, Welhorn LG, Coté CJ, Davis PJ, Dinner M, Hannallah RS, Liu LMP, Sarner J, McGill WA, Alifimoff JK, Embree PB, Cook DR (1992) Induction and maintenance characteristics of anesthesia with desflurane and nitrous oxide in infants and children. Anesthesiology 76: 373-378